BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9488447)

  • 1. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.
    Erman B; Cortes M; Nikolajczyk BS; Speck NA; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1322-30. PubMed ID: 9488447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
    Rao E; Dang W; Tian G; Sen R
    J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer.
    Dang W; Sun XH; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1477-88. PubMed ID: 9488464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins.
    Tian G; Erman B; Ishii H; Gangopadhyay SS; Sen R
    Mol Cell Biol; 1999 Apr; 19(4):2946-57. PubMed ID: 10082562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise alignment of sites required for mu enhancer activation in B cells.
    Nikolajczyk BS; Nelsen B; Sen R
    Mol Cell Biol; 1996 Aug; 16(8):4544-54. PubMed ID: 8754855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
    Sun W; Graves BJ; Speck NA
    J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring functional redundancy in the immunoglobulin mu heavy-chain gene enhancer.
    Dang W; Nikolajczyk BS; Sen R
    Mol Cell Biol; 1998 Nov; 18(11):6870-8. PubMed ID: 9774700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
    Zaiman AL; Nieves A; Lenz J
    J Virol; 1998 Apr; 72(4):3129-37. PubMed ID: 9525638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative binding of Ets-1 and core binding factor to DNA.
    Wotton D; Ghysdael J; Wang S; Speck NA; Owen MJ
    Mol Cell Biol; 1994 Jan; 14(1):840-50. PubMed ID: 8264651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer.
    Nikolajczyk BS; Sanchez JA; Sen R
    Immunity; 1999 Jul; 11(1):11-20. PubMed ID: 10435575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
    Erman B; Sen R
    EMBO J; 1996 Sep; 15(17):4665-75. PubMed ID: 8887557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
    Baum C; Itoh K; Meyer J; Laker C; Ito Y; Ostertag W
    J Virol; 1997 Sep; 71(9):6323-31. PubMed ID: 9261349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IgH enhancer that drives transcription through basic helix-loop-helix and Oct transcription factor binding motifs. Functional analysis of the E(mu)3' enhancer of the catfish.
    Cioffi CC; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Biol Chem; 2001 Jul; 276(30):27825-30. PubMed ID: 11375977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 co-activates transcription in B cells through indirect association with DNA.
    McCarthy KM; McDevit D; Andreucci A; Reeves R; Nikolajczyk BS
    J Biol Chem; 2003 Oct; 278(43):42106-14. PubMed ID: 12907668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL; Lenz J
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.
    Grant PA; Thompson CB; Pettersson S
    EMBO J; 1995 Sep; 14(18):4501-13. PubMed ID: 7556093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
    Wang S; Wang Q; Crute BE; Melnikova IN; Keller SR; Speck NA
    Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.